Xie Y - Search Results

1

Elucidating the relationship between dyslipidemia and osteoporosis: A multicenter, prospective cohort study protocol.

Wei X, Zhang Y, Sun C, Qi B, Huang X, Chen M, Liu N, Sun K, Chen X, Qin X, Xie Y, Zhu L. Wei X, et al. Among authors: xie y. Front Cardiovasc Med. 2022 Sep 14;9:901786. doi: 10.3389/fcvm.2022.901786. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36186975 Free PMC article.

2

[Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs].

Xie Y, Wei X. Xie Y, et al. Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2768-70. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22292360 Chinese.

3

[Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke].

Wei X, Ye X, Xie Y, Zou Y, Zhao X, Han J, Wang X, Ma Y, Bi Q, Xie Q, Zhao J, Cao X, Chen H, Wang S, Yan R, Han Z, Yi D, Wang Y. Wei X, et al. Among authors: xie y, xie q. Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2789-92. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22292366 Clinical Trial. Chinese.

4

[Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke].

Ye X, Wei X, Xie Y, Zou Y, Zhao X, Han J, Wang X, Ma Y, Bi Q, Xie Q, Zhao J, Cao X, Chen H, Wang S, Yan R, Han Z, Yi D, Wang Y. Ye X, et al. Among authors: xie y, xie q. Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2793-5. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22292367 Clinical Trial. Chinese.

5

[Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine].

Wei X, Zhang Z, Xie Y, Wang Y. Wei X, et al. Among authors: xie y. Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2874-6. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22292389 Chinese.

6

[Skin test: guide of post-marketed re-evaluation of clinical safety in traditional Chinese medicine injection].

Wei X, Xie Y, Wang Y. Wei X, et al. Among authors: xie y. Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2877-9. Zhongguo Zhong Yao Za Zhi. 2011. PMID: 22292390 Chinese.

7

Population pharmacokinetics of naringin in total flavonoids of Drynaria fortunei (Kunze) J. Sm. in Chinese women with primary osteoporosis.

Wang JN, Jiang JJ, Xie YM, Wei X, Li JP, Duan JL, Xiong X. Wang JN, et al. Chin J Integr Med. 2012 Dec;18(12):925-33. doi: 10.1007/s11655-012-1296-0. Epub 2012 Dec 13. Chin J Integr Med. 2012. PMID: 23239001

8

[Principle of adverse drug reaction causality judgement and interpretation of causality assessment method both in China and abroad].

Wei X, Xie YM. Wei X, et al. Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(18):2744-7. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 23285925 Chinese.

9

[Influencing factor and mechanism analysis of adverse drug reaction in traditional Chinese medicine injection].

Wei X, Xie YM. Wei X, et al. Zhongguo Zhong Yao Za Zhi. 2012 Sep;37(18):2748-51. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 23285926 Chinese.

10

[Reasonable application of traditional Chinese medicines injections promoting blood circulation and removing blood stasis in treating ischemic cerebrovascular diseases].

Lv ZG, Xie YM, Li MQ, Zhao JJ, Wei X. Lv ZG, et al. Zhongguo Zhong Yao Za Zhi. 2012 Nov;37(22):3494-9. Zhongguo Zhong Yao Za Zhi. 2012. PMID: 23373229 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26,200 results

Search Page

Filters